Farallon Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $1.24M | Sell |
|
|||||
|
2021
Q4 | $44.3M | Sell |
|
|||||
|
2021
Q3 | $137M | Buy |
|
|||||
|
2021
Q2 | $165M | Buy |
|
|||||
|
2021
Q1 | $157M | Sell |
|
|||||
|
2020
Q4 | $273M | Sell |
|
|||||
|
2020
Q3 | $125M | Sell |
|
|||||
|
2020
Q2 | $120M | Buy |
|
|||||
|
2020
Q1 | $66.6M | Buy |
|
|||||
|
2019
Q4 | $44M | Hold |
|
|||||
|
2019
Q3 | $34.9M | Sell |
|
|||||
|
2019
Q2 | $50.8M | Hold |
|
|||||
|
2019
Q1 | $43.9M | Buy |
|
|||||
|
2018
Q4 | $28.2M | Buy |
|
|||||
|
2018
Q3 | $8.63M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $880K | Sell |
|
|||||
|
2014
Q2 | $1.57M | Sell |
|
|||||
|
2014
Q1 | $2.68M | Sell |
|
|||||
|
2013
Q4 | $3.42M | Buy |
|